Effect of inoculum density on susceptibility of Plesiomonas shigelloides to cephalosporins

Journal of Antimicrobial Chemotherapy

Volumn 54, Issue 2, 2004, Pages 418-423

  Wiegand, Irith ^a   Burak, Sonja ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

lactamases; Filamentation; Inoculum effect

Indexed keywords

BETA LACTAMASE; CEFIXIME; CEFOTAXIME; CEFOTIAM; CEFPODOXIME; CEFTAZIDIME; CEFTIBUTEN; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN DERIVATIVE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATE; CELL DENSITY; CELL KINETICS; CELL STRUCTURE; CONTROLLED STUDY; DILUTION; DRUG CYTOTOXICITY; ENZYME ACTIVITY; ENZYME REGULATION; ENZYME SYNTHESIS; INOCULATION; ISOELECTRIC FOCUSING; MICROSCOPY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PLESIOMONAS SHIGELLOIDES; POLYACRYLAMIDE GEL ELECTROPHORESIS; STRAIN DIFFERENCE;

BETA-LACTAMASES; CEPHALOSPORINS; COLONY COUNT, MICROBIAL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ESCHERICHIA COLI; ISOELECTRIC FOCUSING; KINETICS; MICROBIAL SENSITIVITY TESTS; PLESIOMONAS;

EID: 4444282433     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkh322     Document Type: Article

References (37)

1. Farmer, J. J., Arduino, M. J. & Hickmann-Brenner, F. W. (1992). The genera Aeromonas and Plesiomonas. In The Procaryotes. (Balows, A., Trueper, H. G., Dworkin, M. et al., Eds), pp. 3012-45. Springer, New York, NY, USA.
2. Shigematsu, M., Kaufmann, M. E., Charlett, A. et al. (2000). An epidemiological study of Plesiomonas shigelloides diarrhoea among Japanese travellers. Epidemiology and Infection 125, 523-30.
3. Theodoropoulos, C., Wong, T. H., O'Brien, M. et al. (2001). Plesiomonas shigelloides enters polarized human intestinal Caco-2 cells in an in vitro model system. Infection and Immunity 69, 2260-9.
4. Tseng, H. K., Liu, C. P., Li, W. C. et al. (2002). Characteristics of Plesiomonas shigelloides infection in Taiwan. Journal of Microbiology, Immunology, and Infection 35, 47-52.
5. Lee, A. C., Yuen, K. Y., Ha, S. Y. et al. (1996). Plesiomonas shigelloides septicemia: case report and literature review. Pediatric Hematology and Oncology 13, 265-9.
6. Stock, I. & Wiedemann, B. (2001). β-Lactam-susceptibility patterns of Plesiomonas shigelloides strains: importance of inoculum and medium. Scandinavian Journal of Infectious Diseases 33, 692-6.
7. Bedenic, B., Beader, N. & Zagar, Z. (2001). Effect of inoculum size on the antibacterial activity of cefpirome and cefepime against Klebsiella pneumoniae strains producing SHV extended-spectrum β-lactamases. Clinical Microbiology and Infection 7, 626-35.
8. Johnson, C. C., Livornese, L., Gold, M. J. et al. (1995). Activity of cefepime against ceftazidime-resistant Gram-negative bacilli using low and high inocula. Journal of Antimicrobial Chemotherapy 35, 765-73.
9. Thomson, K. S. & Moland, E. S. (2001). Cefepime, piperacillin-tazobactam, and the inoculum effect in tests with extended-spectrum β-lactamase-producing Enterobacteriaceae. Antimicrobial Agents and Chemotherapy 45, 3548-54.
10. Avison, M. B., Bennett, P. M. & Walsh, T. R. (2000). β-Lactamase expression in Plesiomonas shigelloides. Journal of Antimicrobial Chemotherapy 45, 877- 80.
11. Stock, I. & Wiedemann, B. (2001). Natural antimicrobial susceptibilities of Plesiomonas shigelloides strains. Journal of Anti-microbial Chemotherapy 48, 803-11.
12. Lowry, O. H., Rosenbrough, N. J., Farr, N. J. et al. (1951). Protein measurements with the folin phenol reagent. Journal of Biological Chemistry 193, 265-75.
13. Peter, K., Korfmann, G. & Wiedemann, B. (1988). Impact of the ampD gene and its product on β-lactamase production in Enterobacter cloacae. Reviews of Infectious Diseases 10, 800-5.
14. Brook, I. (1989). Inoculum effect. Reviews of Infectious Diseases 11,361-8.
15. Gould, I. M. & MacKenzie, F. M. (1997). The response of Enterobacteriaceae to β-lactam antibiotics - 'round forms, filaments and the root of all evil'. Journal of Antimicrobial Chemotherapy 40, 495-9.
16. Eng, R. H., Cherubin, C., Smith, S. M. et al. (1985). Inoculum effect of β-lactam antibiotics on Enterobacteriaceae. Antimicrobial Agents and Chemotherapy 28, 601-6.
17. Wise, R., Andrews, J. M., Ashby, J. P. et al. (1990). Ceftibuten-in-vitro activity against respiratory pathogens, β -lactamase stability and mechanism of action. Journal of Antimicrobial Chemotherapy 26, 209-13.
18. Matsubara, N., Minami, S., Matsuhashi, M. et al. (1980). Affinity of cefoperazone for penicillin-binding proteins. Antimicrobial Agents and Chemotherapy 18, 195-9.
19. Hayes, M. V. & Orr, D. C. (1983). Mode of action of ceftazidime: affinity for the penicillin-binding proteins of Escherichia coli K12, Pseudomonas aeruginosa and Staphylococcus aureus. Journal of Antimicrobial Chemotherapy 12, 119-26.
20. Wilson, J. M. & Hunter, P. A. (1986). Comparative antibacterial effects of amoxycillin, amoxycillin/clavulanic acid and cefolaxime against Enterobacteriaceae as determined by turbidimetry, morphology and viable count. Chemotherapy 32, 118-25.
21. Fontana, R., Valisena, S. & Cornaglia, G. (1996). Comparative affinities for penicillin-binding proteins of multipolar ionic amphoteric cephalosporins in Gram-negative bacteria. Journal of Chemotherapy 8, Suppl. 2,23-30.
22. Spratt, B. G. (1975). Distinct penicillin binding proteins involved in the division, elongation, and shape of Escherichia coli K1 2. Proceedings of the National Academy of Sciences, USA 72, 2999-3003.
23. Pogliano, J., Pogliano, K., Weiss, D. S. et al. (1997). Inactivation of Ftsl inhibits constriction of the FtsZ cytokinetic ring and delays the assembly of FtsZ rings at potential division sites. Proceedings of the National Academy of Sciences, USA 94, 559-64.
24. Maki, N., Gestwicki, J. E., Lake, E. M. et al. (2000). Motility and chemotaxis of filamentous cells of Escherichia coli. Journal of Bacteriology 182, 4337-42.
25. Gemmel, C. G. & Lorian, V. (1996). Effects of low concentrations of antibiotics. In Antibiotics in Laboratory Medicine, 4th edn (Lorian, V., Ed.), pp. 397-452. Williams & Wilkins, Baltimore, MD, USA.
26. National Committee for Clinical Laboratory Standards. (2000). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically - Fifth Edition: Approved Standard M7-A5. NCCLS, Villanova, PA, USA.
27. Madigan, M. T., Martinko, J. M. & Parker, J. (2000). Microbial growth. In Brock Microbiology of Microorganisms (Madigan, M. T., Martinko, J. M. & Parker, J., Eds), pp. 135-62. Prentice-Hall Inc., Upper Saddle River, NJ, USA.
28. MacGowan, A. P. & Wise, R. (2001). Establishing MIC breakpoints and the interpretation of in vitro susceptibility tests. Journal of Antimicrobial Chemotherapy 48, Suppl. S1, 17-28.
29. Dofferhoff, A. S., Nijland, J. H., Vries-Hospers, H. G. et al. (1991). Effects of different types and combinations of antimicrobial agents on endotoxin release from Gram-negative bacteria: an in-vitro and in-vivo study. Scandinavian Journal of Infectious Diseases 23, 745-54.
30. Goscinski, G., Lundholm, M., Odenholt, I. et al. (2003). Variation in the propensity to release endotoxin after cefuroxime exposure in different Gram-negative bacteria: uniform and dose-dependent reduction by the addition of tobramycin. Scandinavian Journal of Infectious Diseases 35, 40-6.
31. Jackson, J. J. & Kropp, H. (1992). β-Lactam antibiotic-induced release of free endotoxin: in vitro comparison of penicillin-binding protein (PBP) 2-specific imipenem and PBP 3-specific ceftazidime. Journal of Infectious Diseases 165, 1033-41.
32. Horii, T., Kobayashi, M., Sato, K. et al. (1998). An in-vitro study of carbapenem-induced morphological changes and endotoxin release in clinical isolates of Gram-negative bacilli. Journal of Antimicrobial Chemotherapy 41, 435 -42.
33. Byl, B., Clevenbergh, P., Kentos, A. et al. (2001). Ceftazidime-and imipenem-induced endotoxin release during treatment of Gram-negative infections. European Journal of Clinical Microbiology and Infectious Diseases 20, 804-7.
34. Tsuji, M., Matsuda, H., Miwa, H. et al. (2003). Antimicrobial-induced release of endotoxin from Pseudomonas aeruginosa: comparison of in vitro and animal models. Journal of Antimicrobial Chemotherapy 51, 353-9.
35. Billiet, J., Kuypers, S., Van Lierde, S. et al. (1989). Plesiomonas shigelloides meningitis and septicaemia in a neonate: report of a case and review of the literature. Journal of Infection 19, 267-71.
36. Fujita, K., Shirai, M., Ishioka, T. et al. (1994). Neonatal Plesiomonas shigelloides septicemia and meningitis: a case and review. Acta Paediatrica Japonica 36, 450-2.
37. Jonsson, I., Monsen, T. & Wistrom, J. (1997). A case of Plesiomonas shigelloides cellulitis and bacteraemia from northern Europe. Scandinavian Journal of Infectious Diseases 29, 631-2.